4D Biomaterials secures £1.6m funding
4D Biomaterials, which has developed a new biomaterial used for 3D printing medical implants, has completed a £1.6m funding round.
Facts and Figures
Since April 2000 we have:
- Identified 1,500 innovations
- Agreed 156 licences with external companies
- Filed 750 patents
- Created 100 spin-out companies
- Raised £120 million of venture capital for those companies
- Achieved 4 successful exits, bringing in over £2 million to Warwick
News
NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering
Coventry, United Kingdom, 19th July 2021 – NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeut…
Gibson Group’s work featured on BBC News
The GibsonGroup's work developing a new approach to rapid coronavirus diagnostics has been featured on the BBC - read on the BBC News web pages and watch the BBC news report here.